Context Therapeutics Inc (CNTX)
1.84
+0.03
(+1.66%)
USD |
NASDAQ |
Jul 02, 16:00
1.84
0.00 (0.00%)
After-Hours: 19:58
Context Therapeutics 1 Year Total Returns (Daily): 13.12% for July 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| July 01, 2024 | 13.12% |
| June 28, 2024 | 44.24% |
| June 27, 2024 | 52.27% |
| June 26, 2024 | 50.00% |
| June 25, 2024 | 63.43% |
| June 24, 2024 | 62.69% |
| June 21, 2024 | 68.75% |
| June 20, 2024 | 73.60% |
| June 18, 2024 | 56.59% |
| June 17, 2024 | 50.39% |
| June 14, 2024 | 60.66% |
| June 13, 2024 | 57.60% |
| June 12, 2024 | 58.73% |
| June 11, 2024 | 66.67% |
| June 10, 2024 | 56.91% |
| June 07, 2024 | 22.14% |
| June 06, 2024 | 35.66% |
| June 05, 2024 | 58.93% |
| June 04, 2024 | 41.41% |
| June 03, 2024 | 59.38% |
| May 31, 2024 | 127.6% |
| May 30, 2024 | 104.1% |
| May 29, 2024 | 127.3% |
| May 28, 2024 | 131.8% |
| May 24, 2024 | 153.2% |
| Date | Value |
|---|---|
| May 23, 2024 | 179.4% |
| May 22, 2024 | 202.3% |
| May 21, 2024 | 212.8% |
| May 20, 2024 | 206.6% |
| May 17, 2024 | 266.2% |
| May 16, 2024 | 239.6% |
| May 15, 2024 | 242.7% |
| May 14, 2024 | 207.2% |
| May 13, 2024 | 201.8% |
| May 10, 2024 | 201.6% |
| May 09, 2024 | 204.8% |
| May 08, 2024 | 199.2% |
| May 07, 2024 | 212.8% |
| May 06, 2024 | 223.7% |
| May 03, 2024 | 255.4% |
| May 02, 2024 | 236.2% |
| May 01, 2024 | 138.6% |
| April 30, 2024 | 131.4% |
| April 29, 2024 | 135.8% |
| April 26, 2024 | 145.7% |
| April 25, 2024 | 139.3% |
| April 24, 2024 | 122.6% |
| April 23, 2024 | 131.1% |
| April 22, 2024 | 123.0% |
| April 19, 2024 | 94.15% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-86.74%
Minimum
Dec 09 2022
266.2%
Maximum
May 17 2024
-4.54%
Average
-36.82%
Median
Jun 29 2023
1 Year Total Returns (Daily) Benchmarks
| Emergent BioSolutions Inc | -3.95% |
| AbbVie Inc | 31.61% |
| Revance Therapeutics Inc | -89.85% |
| Design Therapeutics Inc | -48.41% |
| NovaBay Pharmaceuticals Inc | -91.49% |